Sharon Anderson, DPM
Foot & Ankle Surgery · Rolla, MONPI 1417919432
Payments from drug & device makers
Across 80 payments — averaging $53.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Treace Medical Concepts, Inc.$475
- Organogenesis Inc.$339
- Amgen$238
- Elite Orthopedics, LLC$63
- Kerecis Limited$58
- plus $396 from 12 others
What the payments were for
- Travel & lodging$1,22929%
- Food & beverage$3,04471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 32 | $2,705 |
| Treace Medical Concepts, Inc. | 11 | $475 |
| Organogenesis Inc. | 9 | $339 |
| Amgen(2 entities) | 2 | $238 |
| Elite Orthopedics, LLC | 3 | $63 |
| Kerecis Limited | 1 | $58 |
| Smith+Nephew | 3 | $51 |
| ANI Pharmaceuticals, Inc. | 2 | $46 |
| Bioventus LLC | 2 | $44 |
| Misonix Inc | 3 | $43 |
| Axogen | 2 | $39 |
| Integra Lifesciences Corporation | 2 | $38 |
| Averitas Pharma Inc. | 2 | $37 |
| AbbVie | 1 | $30 |
| Checkpoint Surgical, Inc | 1 | $23 |
| Celularity Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Orthofix Medical, Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SALVATION$740
- HOFFMANN$508
- AUGMENT INJECTABLE$339
- Lapiplasty System$271
- KRYSTEXXA$238
- CITREFIX$151
- ORTHOLOC 3DI$127
- BIOskin$105
How this compares
$4,273 in reported general payments places this provider in the 45th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 63 | $2,897 |
| Gabapentin | 18 | $376 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 28 | $345 |
| CiclopiroxCiclopirox Olamine | 16 | $315 |
| Gentamicin Sulfate | 12 | $267 |
| Cilostazol | 16 | $256 |
| SsdSilver Sulfadiazine | 29 | $151 |
| Cephalexin | 16 | $85 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Rolla
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Amar PatelLees Summit$272K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Anthony LombardoBridgeton$132K
- Jason AndersonKansas City$131K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.